Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) major shareholder Financial Lp Hrt sold 3,132,480 shares of the company’s stock in a transaction that occurred on Tuesday, June 16th. The stock was sold at an average price of $0.01, for a total value of $31,324.80. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Financial Lp Hrt also recently made the following trade(s):
- On Friday, June 12th, Financial Lp Hrt bought 4,252,767 shares of Aditxt stock. The stock was purchased at an average price of $0.02 per share, with a total value of $85,055.34.
- On Friday, June 5th, Financial Lp Hrt sold 735,462 shares of Aditxt stock. The stock was sold at an average price of $0.06, for a total value of $44,127.72.
- On Thursday, June 4th, Financial Lp Hrt acquired 843,622 shares of Aditxt stock. The stock was purchased at an average price of $0.08 per share, with a total value of $67,489.76.
- On Friday, April 24th, Financial Lp Hrt sold 1,089 shares of Aditxt stock. The shares were sold at an average price of $7.56, for a total transaction of $8,232.84.
- On Thursday, April 23rd, Financial Lp Hrt sold 141 shares of Aditxt stock. The stock was sold at an average price of $7.83, for a total transaction of $1,104.03.
- On Tuesday, April 21st, Financial Lp Hrt purchased 2,700 shares of Aditxt stock. The stock was acquired at an average price of $8.91 per share, with a total value of $24,057.00.
- On Wednesday, April 22nd, Financial Lp Hrt sold 443 shares of Aditxt stock. The stock was sold at an average price of $8.10, for a total transaction of $3,588.30.
Aditxt Trading Up 136.4%
ADTX traded up $0.01 during midday trading on Thursday, reaching $0.01. The company’s stock had a trading volume of 5,225,393,924 shares, compared to its average volume of 71,900,609. Aditxt, Inc. has a 1 year low of $0.00 and a 1 year high of $53,451.08. The stock’s 50-day moving average is $4.27 and its 200-day moving average is $131.24. The firm has a market capitalization of $8,528.00, a price-to-earnings ratio of -0.00 and a beta of 0.84.
Analyst Ratings Changes
Several equities analysts have recently weighed in on ADTX shares. Wall Street Zen upgraded Aditxt to a “sell” rating in a report on Saturday, May 23rd. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aditxt in a research note on Monday, April 20th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has an average rating of “Sell”.
Check Out Our Latest Stock Analysis on Aditxt
About Aditxt
Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.
The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.
Recommended Stories
- Five stocks we like better than Aditxt
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.
